Form 4: NEOGEN CFO David Naemura Acquires Significant Equity and Options, Signaling Strong Confidence

NEOGEN's Chief Financial Officer, David H. Naemura, has reported the acquisition of 52,724 shares of common stock and 211,723 derivative securities (rights to buy common stock) at an exercise price of $5.69 per share, indicating a substantial increase in his beneficial ownership.

Summary

• David H. Naemura, Chief Financial Officer of NEOGEN CORP, acquired 52,724 shares of common stock on June 2, 2025.
• The acquisition price for the common stock was $5.69 per share.
• Following this transaction, Mr. Naemura directly owns 114,158 shares of common stock.
• Additionally, Mr. Naemura acquired 211,723 derivative securities, specifically 'Right to Buy' common stock, with an exercise price of $5.69.
• These derivative securities have an expiration date of June 2, 2035.
• Both the acquired options and Restricted Stock Units (RSUs) will vest in equal annual installments on each of the first three anniversary dates of their grants.

Sentiment

Score: 8

Explanation: The acquisition of a substantial number of shares and options by the Chief Financial Officer indicates strong insider confidence in the company's future prospects and valuation, which is a positive signal for investors.

Positives

• Insider acquisition of common stock and derivative securities by the Chief Financial Officer signals strong confidence in the company's future prospects.
• The acquisition of 52,724 shares of common stock at $5.69 per share directly increases the CFO's equity stake, aligning his interests with shareholders.
• The grant of 211,723 derivative securities (options/RSUs) further aligns the CFO's long-term interests with shareholder value creation, as they vest over three years.

Future Outlook

The vesting schedule for the acquired options and RSUs, occurring over three annual installments, suggests a long-term commitment by the Chief Financial Officer, aligning with potential future growth expectations for NEOGEN CORP.

Industry Context

Insider purchases, such as this one by NEOGEN's CFO, are often viewed by the market as a positive indicator, suggesting that management believes the company's stock is undervalued or expects positive developments. This can be particularly impactful in the animal health and food safety diagnostics industry, where long-term strategic vision is crucial.

Related Party Transactions

• The transaction involves the Chief Financial Officer of NEOGEN CORP acquiring company securities, which is a direct related-party transaction as defined by SEC regulations.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal, potentially increasing investor confidence and demand for NEOG shares.
• The vesting schedule of the derivative securities aligns the CFO's long-term financial incentives with the interests of shareholders.

Next Steps

• The acquired options and RSUs will vest in equal annual installments on each of the first three anniversary dates of the grants.

Key Dates

Recommendation

Keywords

NEOGEN CORP, NEOG, SEC Form 4, Insider Trading, Stock Acquisition, Derivative Securities, Options, RSUs, Chief Financial Officer, David H. Naemura, Beneficial Ownership